XML 105 R89.htm IDEA: XBRL DOCUMENT v3.19.3
Stockholders' Equity (SARs Activity) (Details) - SARs - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Aug. 31, 2019
Aug. 31, 2018
SARS Outstanding    
SARS Outstanding as of beginning of period (in shares) 156,801  
SARS exercised (in shares) (33,300)  
SARS Outstanding as of end of period (in shares) 123,501 156,801
Aggregate Intrinsic Value, Outstanding $ 1,278 $ 1,748
Weighted- Average Exercise Price    
Weighted-Average Exercise Price, Outstanding as of beginning of period (in dollars per share) $ 18.41  
Weighted-Average Exercise Price, SARS exercised (in dollars per share) 18.24  
Weighted-Average Exercise Price, Outstanding as of end of period (in dollars per share) $ 18.46 $ 18.41
Weighted- Average Remaining Contractual Life, Outstanding 2 years 1 month 10 days 3 years 1 month 6 days